Patrick Hargutt
Gründer bei Stanley Capital Partners LLP
Aktive Positionen von Patrick Hargutt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Gründer | 01.01.2020 | - |
| Private Equity Investor | 01.01.2020 | - | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | 01.09.2020 | - |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 01.09.2022 | - |
| Stanley Lab, Inc. | Direktor/Vorstandsmitglied | 01.03.2021 | - |
Karriereverlauf von Patrick Hargutt
Ehemalige bekannte Positionen von Patrick Hargutt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Direktor/Vorstandsmitglied | - | 12.06.2023 |
| Finanzdirektor/CFO | - | 12.06.2023 | |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Private Equity Investor | 01.01.2018 | 31.10.2019 |
Ausbildung von Patrick Hargutt
| Technische Universität München | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Deutschland | 2 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 4 |
| Private Equity Investor | 2 |
| Founder | 1 |
Sektoral
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finance |
| Private Unternehmen | 5 |
|---|---|
| Stanley Lab, Inc. | |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
- Börse
- Insiders
- Patrick Hargutt
- Erfahrung
